论文部分内容阅读
一、前言:自从瑞典的 Elmqvist 和 Sennig 在1958年埋藏了第一个心脏起搏器以来,应用起搏器进行永久性起搏已经成为治疗症状性心动过缓的最有效的方法。由于起搏器的广泛应用,使上百万病人免于死亡并能维持正常生活和工作。起搏器技术和工艺的进步使得起搏器的可靠性和寿命有了明显改进,应用指征也逐渐扩大,因此,使用起搏器的病人数正在在逐年增加。我国从1974年第一例埋藏起搏器以来,在这方面已经取得了很大的进展。仅在我院就已经进行了194例埋藏手术。在起搏器生产技术方面,我国已经能够研制出一些不同类
I. INTRODUCTION: Since Sweden’s Elmqvist and Sennig buried their first pacemaker in 1958, permanent pacing with pacemakers has become the most effective treatment for symptomatic bradycardia. Due to the wide application of pacemakers, millions of patients are prevented from dying and can maintain normal life and work. The advances in pacemaker technology and processes have resulted in significant improvements in the reliability and longevity of pacemakers, and application indications have also gradually expanded. As a result, the number of patients using pacemakers is increasing year by year. Since our country first buried a pacemaker in 1974, great progress has been made in this area. Only 194 cases have been performed in our hospital. In pacemaker production technology, China has been able to develop some different types of